What are the major opportunities in the Rotavirus Prophylaxis market? What are the strategies for the Rotavirus Prophylaxis market?

For detailed insights on the major opportunities and strategies in the Rotavirus Prophylaxis market, Read More

How does the Rotavirus Prophylaxis market relate to the overall economy and other similar markets?

For detailed insights on Rotavirus Prophylaxis's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Rotavirus Prophylaxis market growth? SWOT analysis of the Rotavirus Prophylaxis market.

For detailed insights on the key dynamics influencing the Rotavirus Prophylaxis market growth and SWOT analysis of the Rotavirus Prophylaxis industry, Read More

Rotavirus Prophylaxis Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Rotavirus Prophylaxis Market Report 2026

Name: Rotavirus Prophylaxis Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment (Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments), By Route of Administration (Oral, Other Route of Administrations), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Rotavirus Prophylaxis Market Overview

• Rotavirus Prophylaxis market size has reached to $9.94 billion in 2025

• Expected to grow to $16.07 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%

• Growth Driver: Institutional Funding Drives Growth In The Rotavirus Prophylaxis Market

• Market Trend: Next-Generation Multivalent Vaccine Innovations Expanding Protection Against Diverse Rotavirus Strains

• North America was the largest region in 2025.

What Is Covered Under Rotavirus Prophylaxis Market?

Rotavirus prophylaxis refers to the prevention of rotavirus infection through vaccination, which protects infants and young children from a highly infectious illness that causes stomach and bowel inflammation. The purpose is to protect from person from any severity.

The main types of treatment for rotavirus prophylaxis are rotarix, rotavac, rotavin-m1, oral rehydration fluid and others. Rotavirus is a virus that causes severe stomach or intestinal sickness such as fever, vomiting and diarrhea. The various routes of administration are oral, parenteral and others channeled through hospital pharmacy, retail pharmacy, online pharmacy and others. The end users are hospitals, specialty clinics, home care and others.

Rotavirus Prophylaxis Market Global Report 2026 Market Report bar graph

What Is The Rotavirus Prophylaxis Market Size and Share 2026?

The rotavirus prophylaxis market size has grown strongly in recent years. It will grow from $9.94 billion in 2025 to $10.87 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to reduction in child mortality through vaccination, increased global immunization coverage, wider availability of oral rotavirus vaccines, growing support from global health organizations, expansion of hospital-based vaccination programs.

What Is The Rotavirus Prophylaxis Market Growth Forecast?

The rotavirus prophylaxis market size is expected to see rapid growth in the next few years. It will grow to $16.07 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing focus on universal vaccine coverage, rising investments in pediatric vaccine development, expansion of vaccination programs in emerging economies, growing demand for affordable vaccine formulations, strengthening of immunization infrastructure. Major trends in the forecast period include increasing expansion of national immunization programs, rising adoption of oral rotavirus vaccines, growing focus on pediatric preventive healthcare, enhanced cold-chain distribution management, expansion of public-private vaccination initiatives.

Book your 30 minutes free consultation with our research experts

Global Rotavirus Prophylaxis Market Segmentation

1) By Treatment: Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments

2) By Route of Administration: Oral, Other Route of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Rotarix: Single Dose, Multi-Dose

2) By Rotavac: Liquid Formulation, Freeze-Dried Formulation

3) By Rotavin-M1: Liquid Formulation, Freeze-Dried Formulation

4) By Oral Rehydration Fluid: Electrolyte Solutions, Glucose-Based Solutions

5) By Other Treatments: Supportive Care, Antidiarrheal Medications

What Is The Driver Of The Rotavirus Prophylaxis Market?

Funding from institutions is expected to propel the growth of rotavirus prophylaxis market. Funding from institutions refers to the provision of resources in the form of money, effort, or time, to finance a need, program, or project. Rotavirus’ increasing cases attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of rotavirus vaccine and oral medication. For instance, in April 2025, according to the American Medical Association, a US-based professional association for physicians, health spending in the U.S. increased by 7.5% in 2023 to $4.9 trillion or $14,570 per capita. Therefore, increasing the availability of funding will boost the rotavirus prophylaxis industry.

Key Players In The Global Rotavirus Prophylaxis Market

Major companies operating in the rotavirus prophylaxis market are Merck And Co, GlaxoSmithKline plc, Bharat Biotech International Limited, Serum Institute Of India Pvt Ltd, Zydus Lifesciences Ltd, Sinovac Biotech Ltd, Hualan Biological Engineering Inc, Biological E Limited, PT Bio Farma, Panacea Biotec Ltd, Shanghai Institute Of Biological Products, Wuhan Institute Of Biological Products, Lanzhou Institute Of Biological Products, Changchun Institute Of Biological Products, Beijing Institute Of Biological Products, Shenzhen Kangtai Biological Products Co Ltd, Minhai Biotechnology Co Ltd, CanSino Biologics Inc, Bharat Serums And Vaccines Limited, Walvax Biotechnology Co Ltd, Clover Biopharmaceuticals Ltd, SK Bioscience Co Ltd

Global Rotavirus Prophylaxis Market Trends and Insights

Major companies operating in the rotavirus prophylaxis market are focusing on technological advancements, such as reassortant hexavalent oral vaccines, to meet the rising demand driven by the need for broader serotype coverage and enhanced protection against diverse rotavirus strains prevalent globally. Reassortant hexavalent vaccines are developed using advanced viral reassortment technology to target six dominant rotavirus serotypes (G1, G2, G3, G4, G9, and P1A), thereby providing broad-spectrum protection superior to traditional monovalent or pentavalent vaccines. For instance, in March 2024, Sinovac Biotech Ltd., a China-based biopharmaceutical company, initiated Phase 1 clinical trials for its live, oral reassortant hexavalent rotavirus vaccine, aiming to evaluate safety, tolerability, and immunogenicity across adults, children, and infants. This vaccine’s composition leverages Vero cell technology and aims to generate robust immune responses against multiple strains, addressing changing epidemiology and prevalent serotypes with superior effectiveness. Its innovative approach allows better global immunization coverage, especially in regions where rotavirus shows high genetic diversity.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Rotavirus Prophylaxis Market?

In June 2024, Murdoch Children’s Research Institute (MCRI), an Australia-based child-health research institute, partnered with Incepta Pharmaceuticals for their RV3-BB rotavirus vaccine to expand access to its neonatal/infant rotavirus vaccine in high-burden regions by leveraging Incepta’s manufacturing capacity and market reach. Incepta Pharmaceuticals is a Bangladesh-based leading pharmaceutical company that develops, manufactures, and distributes a broad range of vaccines and pharmaceutical products.

Regional Outlook

North America was the largest region in the rotavirus prophylaxis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rotavirus Prophylaxis Market?

The rotavirus prophylaxis market consists of revenues earned by entities by providing services such as vaccination, clinical management, awareness programs and diagnosis. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rotavirus Prophylaxis Market Report 2026?

The rotavirus prophylaxis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rotavirus prophylaxis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Rotavirus Prophylaxis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$10.87 billion
Revenue Forecast In 2035	$16.07 billion
Growth Rate	CAGR of 9.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment, Route of Administration, Distribution Channel, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Merck And Co, GlaxoSmithKline plc, Bharat Biotech International Limited, Serum Institute Of India Pvt Ltd, Zydus Lifesciences Ltd, Sinovac Biotech Ltd, Hualan Biological Engineering Inc, Biological E Limited, PT Bio Farma, Panacea Biotec Ltd, Shanghai Institute Of Biological Products, Wuhan Institute Of Biological Products, Lanzhou Institute Of Biological Products, Changchun Institute Of Biological Products, Beijing Institute Of Biological Products, Shenzhen Kangtai Biological Products Co Ltd, Minhai Biotechnology Co Ltd, CanSino Biologics Inc, Bharat Serums And Vaccines Limited, Walvax Biotechnology Co Ltd, Clover Biopharmaceuticals Ltd, SK Bioscience Co Ltd
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Rotavirus Prophylaxis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Rotavirus Prophylaxis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Rotavirus Prophylaxis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Rotavirus Prophylaxis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Expansion Of National Immunization Programs

4.2.2 Rising Adoption Of Oral Rotavirus Vaccines

4.2.3 Growing Focus On Pediatric Preventive Healthcare

4.2.4 Enhanced Cold-Chain Distribution Management

4.2.5 Expansion Of Public-Private Vaccination Initiatives

5. Rotavirus Prophylaxis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Providers

5.4 Hospital Pharmacies

5.5 Retail Pharmacies

6. Rotavirus Prophylaxis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rotavirus Prophylaxis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Rotavirus Prophylaxis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Rotavirus Prophylaxis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Rotavirus Prophylaxis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Rotavirus Prophylaxis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rotavirus Prophylaxis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rotavirus Prophylaxis Market Segmentation

9.1. Global Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments

9.2. Global Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Other Route of Administrations

9.3. Global Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

9.4. Global Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare, Other End-Users

9.5. Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotarix, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Dose, Multi-Dose

9.6. Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotavac, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Liquid Formulation, Freeze-Dried Formulation

9.7. Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotavin-M1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Liquid Formulation, Freeze-Dried Formulation

9.8. Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Oral Rehydration Fluid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Electrolyte Solutions, Glucose-Based Solutions

9.9. Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Supportive Care, Antidiarrheal Medications

10. Rotavirus Prophylaxis Market Regional And Country Analysis

10.1. Global Rotavirus Prophylaxis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Rotavirus Prophylaxis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rotavirus Prophylaxis Market

11.1. Asia-Pacific Rotavirus Prophylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rotavirus Prophylaxis Market

12.1. China Rotavirus Prophylaxis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rotavirus Prophylaxis Market

13.1. India Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rotavirus Prophylaxis Market

14.1. Japan Rotavirus Prophylaxis Market Overview

14.2. Japan Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rotavirus Prophylaxis Market

15.1. Australia Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rotavirus Prophylaxis Market

16.1. Indonesia Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rotavirus Prophylaxis Market

17.1. South Korea Rotavirus Prophylaxis Market Overview

17.2. South Korea Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rotavirus Prophylaxis Market

18.1. Taiwan Rotavirus Prophylaxis Market Overview

18.2. Taiwan Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rotavirus Prophylaxis Market

19.1. South East Asia Rotavirus Prophylaxis Market Overview

19.2. South East Asia Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rotavirus Prophylaxis Market

20.1. Western Europe Rotavirus Prophylaxis Market Overview

20.2. Western Europe Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rotavirus Prophylaxis Market

21.1. UK Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rotavirus Prophylaxis Market

22.1. Germany Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rotavirus Prophylaxis Market

23.1. France Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rotavirus Prophylaxis Market

24.1. Italy Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rotavirus Prophylaxis Market

25.1. Spain Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rotavirus Prophylaxis Market

26.1. Eastern Europe Rotavirus Prophylaxis Market Overview

26.2. Eastern Europe Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rotavirus Prophylaxis Market

27.1. Russia Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rotavirus Prophylaxis Market

28.1. North America Rotavirus Prophylaxis Market Overview

28.2. North America Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rotavirus Prophylaxis Market

29.1. USA Rotavirus Prophylaxis Market Overview

29.2. USA Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rotavirus Prophylaxis Market

30.1. Canada Rotavirus Prophylaxis Market Overview

30.2. Canada Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rotavirus Prophylaxis Market

31.1. South America Rotavirus Prophylaxis Market Overview

31.2. South America Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rotavirus Prophylaxis Market

32.1. Brazil Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rotavirus Prophylaxis Market

33.1. Middle East Rotavirus Prophylaxis Market Overview

33.2. Middle East Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rotavirus Prophylaxis Market

34.1. Africa Rotavirus Prophylaxis Market Overview

34.2. Africa Rotavirus Prophylaxis Market, Segmentation By Treatment, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rotavirus Prophylaxis Market Regulatory and Investment Landscape

36. Rotavirus Prophylaxis Market Competitive Landscape And Company Profiles

36.1. Rotavirus Prophylaxis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Rotavirus Prophylaxis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Rotavirus Prophylaxis Market Company Profiles

36.3.1. Merck And Co Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bharat Biotech International Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Serum Institute Of India Pvt Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Zydus Lifesciences Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Rotavirus Prophylaxis Market Other Major And Innovative Companies

Sinovac Biotech Ltd, Hualan Biological Engineering Inc, Biological E Limited, PT Bio Farma, Panacea Biotec Ltd, Shanghai Institute Of Biological Products, Wuhan Institute Of Biological Products, Lanzhou Institute Of Biological Products, Changchun Institute Of Biological Products, Beijing Institute Of Biological Products, Shenzhen Kangtai Biological Products Co Ltd, Minhai Biotechnology Co Ltd, CanSino Biologics Inc, Bharat Serums And Vaccines Limited, Walvax Biotechnology Co Ltd

38. Global Rotavirus Prophylaxis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rotavirus Prophylaxis Market

40. Rotavirus Prophylaxis Market High Potential Countries, Segments and Strategies

40.1 Rotavirus Prophylaxis Market In 2030 - Countries Offering Most New Opportunities

40.2 Rotavirus Prophylaxis Market In 2030 - Segments Offering Most New Opportunities

40.3 Rotavirus Prophylaxis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Rotavirus Prophylaxis Market, Overview Of Key Products - Product Examples

Table 2: Global Rotavirus Prophylaxis Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Rotavirus Prophylaxis Market, Supply Chain Analysis

Table 4: Global Rotavirus Prophylaxis Market, Major Raw Material Providers

Table 5: Global Rotavirus Prophylaxis Market, Major Resource Providers

Table 6: Global Rotavirus Prophylaxis Market, Major Manufacturers (Suppliers)

Table 7: Global Rotavirus Prophylaxis Market, Major Distributors And Channel Partners

Table 8: Global Rotavirus Prophylaxis Market, Key Technologies & Future Trends

Table 9: Global Rotavirus Prophylaxis Market, Major Trends

Table 10: Global Rotavirus Prophylaxis Market, Major End Users

Table 11: Global Rotavirus Prophylaxis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Rotavirus Prophylaxis Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Rotavirus Prophylaxis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Rotavirus Prophylaxis Market - TAM, US$ Billion, 2025

Table 15: Global Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotarix, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotavac, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotavin-M1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Oral Rehydration Fluid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Rotavirus Prophylaxis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Rotavirus Prophylaxis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Rotavirus Prophylaxis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Rotavirus Prophylaxis Market - Company Scoring Matrix

Table 100: Merck And Co Financial Performance

Table 101: GlaxoSmithKline plc Financial Performance

Table 102: Bharat Biotech International Limited Financial Performance

Table 103: Serum Institute Of India Pvt Ltd Financial Performance

Table 104: Zydus Lifesciences Ltd Financial Performance

Table 105: Global Rotavirus Prophylaxis Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Rotavirus Prophylaxis Market, Competitive Dashboard

Table 107: Global Rotavirus Prophylaxis Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Rotavirus Prophylaxis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Table 109: Global, Rotavirus Prophylaxis Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Table 110: Global, Rotavirus Prophylaxis Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Rotavirus Prophylaxis Market, Overview Of Key Products - Product Examples

Figure 2: Global Rotavirus Prophylaxis Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Rotavirus Prophylaxis Market, Supply Chain Analysis

Figure 4: Global Rotavirus Prophylaxis Market, Major Raw Material Providers

Figure 5: Global Rotavirus Prophylaxis Market, Major Resource Providers

Figure 6: Global Rotavirus Prophylaxis Market, Major Manufacturers (Suppliers)

Figure 7: Global Rotavirus Prophylaxis Market, Major Distributors And Channel Partners

Figure 8: Global Rotavirus Prophylaxis Market, Key Technologies & Future Trends

Figure 9: Global Rotavirus Prophylaxis Market, Major Trends

Figure 10: Global Rotavirus Prophylaxis Market, Major End Users

Figure 11: Global Rotavirus Prophylaxis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Rotavirus Prophylaxis Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Rotavirus Prophylaxis Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Rotavirus Prophylaxis Market - TAM, US$ Billion, 2025

Figure 15: Global Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Rotavirus Prophylaxis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotarix, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotavac, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Rotavin-M1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Oral Rehydration Fluid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Rotavirus Prophylaxis Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Rotavirus Prophylaxis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Rotavirus Prophylaxis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Rotavirus Prophylaxis Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Rotavirus Prophylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Rotavirus Prophylaxis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Rotavirus Prophylaxis Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Rotavirus Prophylaxis Market - Company Scoring Matrix

Figure 100: Merck And Co Financial Performance

Figure 101: GlaxoSmithKline plc Financial Performance

Figure 102: Bharat Biotech International Limited Financial Performance

Figure 103: Serum Institute Of India Pvt Ltd Financial Performance

Figure 104: Zydus Lifesciences Ltd Financial Performance

Figure 105: Global Rotavirus Prophylaxis Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Rotavirus Prophylaxis Market, Competitive Dashboard

Figure 107: Global Rotavirus Prophylaxis Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Rotavirus Prophylaxis Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Figure 109: Global, Rotavirus Prophylaxis Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Figure 110: Global, Rotavirus Prophylaxis Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Veterinary Antibiotics Market Report 2026 - Global Outlook – By Product (Anti-Parasitic, Anti-Bacterial, Non-Steroidal Anti-Inflammatory Drug, Other Products), By Administration (Premixes, Injections, Oral Powders, Oral ...

Gastric Volvulus Treatment Market Report 2026 - Global Outlook – By Type (Organo-Axial Volvulus, Mesentero-Axial Volvulus), By Treatment Type (Medication, Surgery), By Route Of Administration (Oral, Parenteral), By Distr...

Herpes Simplex Virus Treatment Market Report 2026 - Global Outlook – By Type (Herpes Simplex Virus-1 Infection, Herpes Simplex Virus-2 Infection), By Drug Type (Acyclovir, Valacyclovir, Famciclovir, Other Drugs), By Rout...

Panuveitis Treatment Market Report 2026 - Global Outlook – By Drug Class (Anti-Inflammatory, Antimicrobial Drugs, Immunotherapy And Targeted Therapies), By Route Of Administration (Oral, Topical), By End Users (Hospitals...

Rotavirus Prophylaxis Market Report 2026 - Global Outlook – By Treatment (Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments), By Route of Administration (Oral, Other Route of Administrations), By Dis...

Rotavirus Vaccine Market Report 2026 - Global Outlook – By Type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types), By Application (Adult, Pediatric), By End Users (Hospitals, Clinics, Academic Research) ...

Viral Gastroenteritis Market Report 2026 - Global Outlook – By Drugs (Antibiotics, Antacids, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdo...

Frequently Asked Questions

How big is the Rotavirus Prophylaxis Market?

The Rotavirus Prophylaxis market was valued at $9.94 billion in 2025, increased to $10.87 billion in 2026, and is projected to reach $16.07 billion by 2030.

What is the Rotavirus Prophylaxis market growth?

The global Rotavirus Prophylaxis market is expected to grow at a CAGR of 10.3% from 2026 to 2035 to reach $16.07 billion by 2035.

Who are the key players in Rotavirus Prophylaxis market?

Some Key Players in the Rotavirus Prophylaxis market Include, Merck And Co, GlaxoSmithKline plc, Bharat Biotech International Limited, Serum Institute Of India Pvt Ltd, Zydus Lifesciences Ltd, Sinovac Biotech Ltd, Hualan Biological Engineering Inc, Biological E Limited, PT Bio Farma, Panacea Biotec Ltd, Shanghai Institute Of Biological Products, Wuhan Institute Of Biological Products, Lanzhou Institute Of Biological Products, Changchun Institute Of Biological Products, Beijing Institute Of Biological Products, Shenzhen Kangtai Biological Products Co Ltd, Minhai Biotechnology Co Ltd, CanSino Biologics Inc, Bharat Serums And Vaccines Limited, Walvax Biotechnology Co Ltd, Clover Biopharmaceuticals Ltd, SK Bioscience Co Ltd .

What is the anticipated growth trend for the Rotavirus Prophylaxis market?

Major trend in this market includes: Next-Generation Multivalent Vaccine Innovations Expanding Protection Against Diverse Rotavirus Strains. For further insights on this market. request a sample here

Which region has the most growth potential in the Rotavirus Prophylaxis market?

North America was the largest region in the rotavirus prophylaxis market in 2025. The regions covered in the rotavirus prophylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.